Lanatoside c
- Level
- Commodity
- Parent
- 51121900
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51121910This classification denotes a lanatoside, digilanide, and cardiac glycoside with the molecular formula C49H76O20, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5RR3JFZ771, chemically known as 3-((o beta-d-glucopyranosyl-(1-4)-o-3beta-o-acetyl-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1-4)-o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1-4)-o-2,6-dideoxy-beta-d-ribo-hexopyranosyl)oxy)-12beta,14-dihydroxy-5beta-card-20(22)-enolide but generally known as lanatoside c, which bears US NIH Compound Identifier 3879. European Medicines Agency schedules Lanatoside c in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08395MIG. World Health Organization schedules lanatoside c in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule lanatoside c under HS 29389010 and SITC 54161. As of Q4 2014, LANATOSIDE C remains the US FDA Preferred Term for this commodity. SMILES: OC12C3C(C4(C(CC3)CC(OC3OC(C(OC5OC(C(OC6OC(C(OC7OC(C(O)C(O)C7O)CO)C(OC(=O)C)C6)C)C(O)C5)C)C(O)C3)C)CC4)C)CC(O)C1(C(CC2)C1=CC(=O)OC1)C.
Same parent
Under 51121900 · 19Activities that produce or sell this
KBLI · 8Inherited from family 51120000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.